PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

Take a look at our infographic!

Photo: Damien Schumann

Dr Halidou Tinto elected Fellow of the African Academy of Sciences

Photo: Dr Tinto – ©IT CRUN

Read EDCTP's interview with Dr Tim Wells, Chief Scientific Officer of MMV

Photo: BrianAJackson/iStock

Take a look at our infosheet!

Photo: Alex Radelich

Portfolio approach to developing the next-generation of malaria treatments for Africa

Work packages

Next-generation drug combination for uncomplicated malaria

First malaria treatment for babies under 5kg

New medicine for treatment of severe malaria

Building research capacity in Africa

Consortium Partners

MMV

Medicines for Malaria Venture (MMV) is a leading product development partnership (PDP) in antimalarial drug research in its 20th year.

Novartis

Novartis is reimagining medicine to improve and extend people’s lives.

The Eberhard Karls Universität Tübingen

The Eberhard Karls Universität Tübingen is one of Europe’s oldest universities, with key strengths in Sciences and Life Sciences. Within the Faculty of Medicine, the Institute of Tropical Medicine (ITM) is an established Centre of Excellence (since 2007).

CERMEL

Manhiça Health Research Centre

Manhiça Health Research Centre is a research institution managed by Manhiça Foundation, whose mission is to promote and conduct biomedical research in health priority areas to promote and safeguard the health of the population.

GRAS

The Groupe de Recherche Action en Santé (GRAS) is a private institute based in Burkina Faso, operating since 2008 in the field of health research.

IDRC

IDRC conducts research in infectious diseases including Malaria, HIV, Tuberculosis and other diseases of public health importance through collaboration and partnership.